Contract Pharmaceuticals - Ownership and Business Overview

PackagingCompany

Contract Pharmaceuticals Ownership

Who owns Contract Pharmaceuticals?

Contract Pharmaceuticals is owned by Aterian Investment Partners. It was acquired on June 6, 2024.

Is Contract Pharmaceuticals PE-backed?

Yes. Contract Pharmaceuticals is owned by private equity investor Aterian Investment Partners.

Contract Pharmaceuticals Business Overview

Where is Contract Pharmaceuticals headquartered?

Contract Pharmaceuticals is headquartered in Mississauga, Ontario.

What sector is Contract Pharmaceuticals in?

Contract Pharmaceuticals is a packaging company.

Packaging M&A Summary in 2024

Out of 60 sectors in the Mergr database, packaging ranked 28 in number of deals in 2024. The largest packaging acquisition in 2024 was DS Smith - which was acquired by International Paper Company for $9.9B.

Join Mergr to view all 67 acquisitions of packaging companies in 2024, including 12 acquisitions by private equity firms, and 55 by strategics.

Contract Pharmaceuticals

Contract Pharmaceuticals Ltd.

7600 Danbro Crescent,
Mississauga, Ontario L5N 6L6
Canada,
(905) 821-7600
www.cplltd.com

Contract Pharmaceuticals provides development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical prescription and regulated OTC products for markets worldwide. Contract Pharmaceuticals is based in Mississaugam, Ontario.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.